Survival outcomes and treatment patterns in myelofibrosis in the <scp>JAK</scp> inhibitor eraJuan Carlos Hernández‐Boluda, the Spanish MPN Group (GEMFIN), Manuel Pérez‐Encinas et al.|British Journal of Haematology|2026Cited by 0